These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38599495)

  • 1. Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery.
    Tang Y; Liu B; Zhang Y; Liu Y; Huang Y; Fan W
    Adv Drug Deliv Rev; 2024 Jun; 209():115304. PubMed ID: 38599495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanomedicines for lymphatic imaging and therapy.
    He P; Tang H; Zheng Y; Xiong Y; Cheng H; Li J; Zhang Y; Liu G
    J Nanobiotechnology; 2023 Aug; 21(1):292. PubMed ID: 37620846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
    Trevaskis NL; Kaminskas LM; Porter CJ
    Nat Rev Drug Discov; 2015 Nov; 14(11):781-803. PubMed ID: 26471369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration.
    Gracia G; Cao E; Feeney OM; Johnston APR; Porter CJH; Trevaskis NL
    Mol Pharm; 2020 Aug; 17(8):2938-2951. PubMed ID: 32543863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine delivery systems toward lymph nodes.
    Ding Y; Li Z; Jaklenec A; Hu Q
    Adv Drug Deliv Rev; 2021 Dec; 179():113914. PubMed ID: 34363861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-of-the-art drug delivery system to target the lymphatics.
    Khaire OT; Mhaske A; Prasad AG; Almalki WH; Srivastava N; Kesharwani P; Shukla R
    J Drug Target; 2024 Apr; 32(4):347-364. PubMed ID: 38253594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes.
    McCright J; Skeen C; Yarmovsky J; Maisel K
    Acta Biomater; 2022 Jun; 145():146-158. PubMed ID: 35381399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes to target the lymphatics by subcutaneous administration.
    Oussoren C; Storm G
    Adv Drug Deliv Rev; 2001 Aug; 50(1-2):143-56. PubMed ID: 11489337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases: importance of detection and treatment strategies.
    Obinu A; Gavini E; Rassu G; Maestri M; Bonferoni MC; Giunchedi P
    Expert Opin Drug Deliv; 2018 May; 15(5):459-467. PubMed ID: 29504430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.
    Ryan GM; Kaminskas LM; Porter CJ
    J Control Release; 2014 Nov; 193():241-56. PubMed ID: 24801249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport.
    Miao YB; Lin YJ; Chen KH; Luo PK; Chuang SH; Yu YT; Tai HM; Chen CT; Lin KJ; Sung HW
    Adv Mater; 2021 Dec; 33(51):e2104139. PubMed ID: 34596293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a mouse model for the visual and quantitative assessment of lymphatic trafficking and function by in vivo imaging.
    Yamaji Y; Akita S; Akita H; Miura N; Gomi M; Manabe I; Kubota Y; Mitsukawa N
    Sci Rep; 2018 Apr; 8(1):5921. PubMed ID: 29651026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives.
    Lan HR; Zhang YN; Han YJ; Yao SY; Yang MX; Xu XG; Mou XZ; Jin KT
    J Nanobiotechnology; 2023 Aug; 21(1):247. PubMed ID: 37528366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Interactions with the Lymphatic System.
    Jakovija A; Chtanova T
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled Nanocarriers.
    Cabral H; Makino J; Matsumoto Y; Mi P; Wu H; Nomoto T; Toh K; Yamada N; Higuchi Y; Konishi S; Kano MR; Nishihara H; Miura Y; Nishiyama N; Kataoka K
    ACS Nano; 2015 May; 9(5):4957-67. PubMed ID: 25880444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
    Ali Khan A; Mudassir J; Mohtar N; Darwis Y
    Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities.
    Kraft JC; Treuting PM; Ho RJY
    J Drug Target; 2018; 26(5-6):494-504. PubMed ID: 29388438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles in detection and treatment of lymph node metastases: an update from the point of view of administration routes.
    Obinu A; Gavini E; Rassu G; Maestri M; Bonferoni MC; Giunchedi P
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1117-1126. PubMed ID: 30322283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.